Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) will be hosting a conference call at 4:30 PM eastern time on 12th November 2020, to discuss its 3Q20 financial results with the investment community.
A live webcast with presentations will be available on the Internet by visiting the Company website www.opiant.com
The participants may dial, 877-407-0792 U.S. or 201-689-8263 Toll Number, and the passcode is 13712206 in order to access the live audio call
Earnings Expectation
Opiant Pharmaceuticals, Inc. is reporting third quarter financial results on Thursday 12th November 2020, after market close.
According to analysts surveyed by Thomson Reuters, OPNT is expected to report 3Q20 loss of $ 0.21 per share from revenue of $ 7.76 million.
For the full year, analysts anticipate top line of $ 27.39 million, while looking forward to loss of $ 0.83 per share bottom line.
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes treatments for opioid overdose; eating disorders, including bulimia nervosa and binge eating disorders; alcohol use disorders; acute cannabinoid overdose; opioid use disorders; and a heroin vaccine.
